Pathophysiology of Type 2 Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 293 of the 297 references it cites were found in a registry or an index.
Abstract
Type 2 Diabetes Mellitus (T2DM), one of the most common metabolic disorders, is caused by a combination of two primary factors: defective insulin secretion by pancreatic β-cells and the inability of insulin-sensitive tissues to respond appropriately to insulin. Because insulin release and activity are essential processes for glucose homeostasis, the molecular mechanisms involved in the synthesis and release of insulin, as well as in its detection are tightly regulated. Defects in any of the mechanisms involved in these processes can lead to a metabolic imbalance responsible for the development of the disease. This review analyzes the key aspects of T2DM, as well as the molecular mechanisms and pathways implicated in insulin metabolism leading to T2DM and insulin resistance. For that purpose, we summarize the data gathered up until now, focusing especially on insulin synthesis, insulin release, insulin sensing and on the downstream effects on individual insulin-sensitive organs. The review also covers the pathological conditions perpetuating T2DM such as nutritional factors, physical activity, gut dysbiosis and metabolic memory. Additionally, because T2DM is associated with accelerated atherosclerosis development, we review here some of the molecular mechanisms that link T2DM and insulin resistance (IR) as well as cardiovascular risk as one of the most important complications in T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“T2D is considered a polygenic condition with considerable heterogeneity in degrees of insulin deficiency and resistance and accounts for >90% of all cases of DM.32”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [32]
The cited source says what the claim attributes to it.
In the citing paper
“Likewise, diabetes is secondary to altered glucose homeostasis [67], and this study suggests a critical role for NHE3 in the regulation of SGLT1, which is the predominant intestinal glucose transporter.”
From Regulation of Enterocyte Brush Border Membrane Primary Na-Absorptive Transporters in Human Intestinal Organoid-Derived Monolayers (2024) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 2×
“A critical component of T2DM is a chronic low-grade inflammatory state, referred to as “metaflammation” [250].”
Background10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · cited 1×
“Among them, the UKPDS post-trial study and Steno-2 trial showed that specifically early glycemic interventions prevent diabetic complication and has a marked decrease in CVD endpoints in patients that received either standard or intensive treatment following their diagnosis [84].”
BackgroundHaffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
ROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931 · cited 1×
“In these circumstances, as a consequence of nutrient overload, electron supply to the mitochondrial ETC increases and the electron excess is transferred to oxygen generating O2− and subsequent hydrogen peroxide [127].”
BackgroundMetabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638 · cited 1×
“A high-fat diet can induce up to threefold lipopolysaccharide (from Gram-negative bacteria) production in mice models, thereby contributing to low-grade inflammation and insulin resistance [76,77].”
BackgroundEckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Research works printed but not linked: 1
- Simmons D. Epigenetic Influences and Disease Nat. Educ. 2008 1 6
Cited by
Items 901–1,000 of 1,005
Adare, A. F., Tiyare, F. T., & Marine, B. T. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01782-3 · Cited by 11
Bibi, R., Zahid, M., Rasool, F., Tariq, M., Hussain, A. S., Asif, H. M., Khan, M. A., Shah, K. H., Hussain, S., Sirajuddin, M., et al. (2024) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2024.125630 · Cited by 8
Argyropoulou, D., Nomikos, T., Terzis, G. D., Tataki, S., Geladas, N. D., & Paschalis, V. (2025) · European Journal of Nutrition · doi:10.1007/s00394-024-03575-9 · Cited by 10
Elfaki, I., Mir, R., Elnageeb, M. E., Hamadi, A., Alharbi, Z. M., Bedaiwi, R. I., Javid, J., Alrasheed, T., Alatawi, D., Alrohaf, B. M., et al. (2025) · Medicina · doi:10.3390/medicina61010083 · Cited by 11
Uddin, M., Mashahid, N., Anta, J. A., & Acharjee, M. R. (2025) · Applied Food Research · doi:10.1016/j.afres.2025.100710 · Cited by 10
Okoro, F. O., & Markus, V. (2025) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.108954 · Cited by 10
Metabolomic network reveals novel biomarkers for type 2 diabetes mellitus in the UK Biobank study
Liu, J., Shang, X., Zhang, X., Chen, Y., Zhang, B., Tang, W., Li, L., Chen, R., Jan, C., Hu, W., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16351 · Cited by 11
“1,7,8 Branched-chain and aromatic amino acids have been identified as early indicators of insulin resistance, 9 yet focusing on individual metabolites risks oversimplifying the intricate metabolic interactions underlying T2DM pathogenesis.”
Gholami, M., Balajam, N. Z., Rakhsha, S. S., Sajjadi‐Jazi, S. M., Shafiee, G., & Heshmat, R. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01604-w · Cited by 9
“One promising class of medications that has emerged in recent years is GLP1RAs [1, 2].”
Peng, T., Miao, R., Xiong, H., Yanhui, L., Fan, D., Ren, J., Wang, J., Li, Y., & Chen, J. (2025) · JMIR Medical Informatics · doi:10.2196/72238 · Cited by 13
“As a condition that can exist before the onset of type 2 diabetes, IR is not only one of the key mechanisms underlying the development of diabetes but also a major risk factor for various diseases [2].”
Popescu, M., Radivojević, K., Trașcă, D.-M., Văruț, R. M., Enache, I., & Osman, A. (2025) · Pharmaceuticals · doi:10.3390/ph18050682 · Cited by 16
“Ultimately, defects in insulin precursor synthesis, insulin production, or secretion mechanisms form the core of β -cell failure, establishing a pathological foundation for T2DM [45].”
Al-hussein, F., Abdollahian, M., Tafakori, L., & Alshali, K. Z. (2025) · PLoS ONE · doi:10.1371/journal.pone.0326315 · Cited by 12
“T2D is a metabolic condition characterised by high blood sugar levels caused by either inadequate insulin synthesis or reduced insulin release by pancreatic β -cells [2].”
Rashid, M., Sarwar, W., Parveen, S., Naz, N., Rida, F., Nawaz, E., Shafiq, N., Alkhalifah, D. H. M., Hozzein, W. N., Mohany, M., et al. (2025) · RSC Advances · doi:10.1039/d5ra01835h · Cited by 8
Pancreatic Islet Cell Hormones: Secretion, Function, and Diabetes Therapy
Ma, J., Mao, L., Yang, L., Xie, Q., Fan, R., Lu, X., Huang, X., Tong, N., & Duan, Z. (2025) · MedComm · doi:10.1002/mco2.70359 · Cited by 20
Flavonoids in Metabolic Disease: A Narrative Review of Mechanisms and Therapeutic Potential
Chen, J., Zhang, K., Yu, X., Ren, J., Kan, C., Sheng, S., Han, F., Zhang, Y., Chen, J., & Sun, X. (2025) · Phytotherapy Research · doi:10.1002/ptr.70107 · Cited by 11
Li, X., Maimaiti, A., Ling, Y., Wan, Y., Cui, H., Tao, Z., Zhang, Z., Wu, Y., Zhao, G., & Zaid, M. (2025) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70109 · Cited by 9
Verma, A., Sharma, M., Alam, O., & Anwer, T. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70364 · Cited by 12
“Individuals with Type 2 diabetes mellitus (T2DM) exhibit hyperglycemia and hyperinsulinemia (Galicia-Garcia et al. 2020).”
Bee products and diabetes mellitus
Maroof, K., & Gan, S. H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85400-9.00012-5 · Cited by 11
Gut microbiome and type 2 diabetes
Patel, S. J., Seshadri, S., & Dalai, S. K. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.06.029 · Cited by 9
Kichi, Z. A., Natarelli, L., Sadeghian, S., Boroumand, M. A., Behmanesh, M., & Weber, C. (2022) · Biomedicines · doi:10.3390/biomedicines10071736 · Cited by 11
“Moreover, monocytes from diabetic patients are characterized by a moderate decrease in the activity of enzymes involved in the modulation of monocyte metabolism and inflammatory activation [8].”
BackgroundPutri, D. M. P., Suhoyo, Y., Pertiwi, A. A. P., & Effendy, C. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277127 · Cited by 18
Role of ceramides in diabetic foot ulcers (Review)
Wang, Y., Sun, Z., Zang, G., Zhang, L., & Wang, Z. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5229 · Cited by 12
Narváez, J. J. U., Us-Medina, U., Muñoz‐Rodriguez, D., & Campos, M. R. S. (2023) · International Journal of Gastronomy and Food Science · doi:10.1016/j.ijgfs.2023.100706 · Cited by 8
Bora, S., Adole, P. S., Vinod, K. V., Pillai, A. A., & Ahmed, S. (2023) · Gene · doi:10.1016/j.gene.2023.147701 · Cited by 8
Mehvari, F., Imanparast, F., Mohaghegh, P., Alimoradian, A., Khansari, N., Asl, B. A., & Khosrowbeygi, A. (2023) · European journal of medical research · doi:10.1186/s40001-023-01254-9 · Cited by 12
“In type 2 DM (T2DM), the blood glucose level elevates due to resistant main regulating organs including liver, fat, and muscles to insulin and prevent the entry of glucose into cells of these tissues [2].”
BackgroundMohanta, B., Sen, D. J., Mahanti, B., & Nayak, A. K. (2023) · Food Bioscience · doi:10.1016/j.fbio.2023.103195 · Cited by 11
Tran, L. T. T., Nguyễn, T. K., Pham, T. V., Ha, T. P., Tran, P. T. D., Tam, V. T. T., Dat, T. T. H., Thai, P. H., & Cường, L. C. V. (2023) · Applied Sciences · doi:10.3390/app132011224 · Cited by 8
Coexistence of hypertension with diabetes mellitus and its pharmacotherapy
Moke, E. G., Demaki, W. E., Daubry, T. M. E., Ataikiru, O., Agbonifo‐Chijiokwu, E., Ofulue, O. O., Ekuerhare, B. E., Akpoyovwere, O., Edje, K. E., & Isibor, N. P. (2023) · Scientia Africana · doi:10.4314/sa.v22i2.14 · Cited by 16
Chang, W., Zhang, L., Wen, L.-Y., Tao, Y.-J., Xiong, J., Tong, X., Jin, Y., & Su, H. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01514-z · Cited by 9
“Different types of diabetes have heterogeneous pathophysiology [37, 38].”
BackgroundOlugbuyi, A. O., Oyinloye, A. M., Araoye, K. T., & Ariseloye, O. (2023) · Journal of Agriculture and Food Research · doi:10.1016/j.jafr.2023.100920 · Cited by 13
Pratama, R. A., Astina, J., & Parikesit, A. A. (2023) · Journal of Tropical Biodiversity and Biotechnology · doi:10.22146/jtbb.83124 · Cited by 8
Naidoo, K., & Khathi, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417609 · Cited by 11
“The response to insulin is diminished in T2DM, which is characterised as insulin resistance [4].”
BackgroundZhu, M., Guan, R., & Ma, G. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1282584 · Cited by 8
Li, C., Yang, Y., Chen, G., Yin, X., Deng, B., Wei, W., Zhang, H., Yuan, M., Xu, Y., Cao, Z., et al. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105989 · Cited by 8
Lin, M. C., Chiu, W.-H., Lin, C., Liu, D., Wu, P.-C., & Lin, C.-S. (2024) · Algal Research · doi:10.1016/j.algal.2024.103414 · Cited by 8
Matayoshi, S., Tojo, F., Suehiro, Y., Okuda, M., Takagi, M., Ochiai, M., Kadono, M., Mikasa, Y., Okawa, R., Nomura, R., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-53213-x · Cited by 12
“T2DM is a metabolic disease characterized by chronic hyperglycemia caused by various degrees of inadequate β-cell insulin secretion and/or insulin resistance 29 .”
BackgroundThe Role of Selenium Nanoparticles in Addressing Diabetic Complications: A Comprehensive Study
Satpathy, S., Panigrahi, L. L., & Arakha, M. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266299494240326083936 · Cited by 10
Mehra, A., & Mehra, A. (2024) · Current Signal Transduction Therapy · doi:10.2174/0115743624282326240418104054 · Cited by 9
Chen, K., Tian, T., Gao, P., Fang, X., Jiang, W., Li, Z., Tang, K., Ouyang, P., & Li, L. (2024) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2023-003966 · Cited by 9
Jiang, P., Di, Z.-H., Huang, W., & Xie, L. (2024) · Molecules · doi:10.3390/molecules29122747 · Cited by 9
Chbel, A., Lafnoune, A., Irahal, I. N., & Bourhim, N. (2024) · Biochimie · doi:10.1016/j.biochi.2024.07.004 · Cited by 10
Putra, I. M. W. A., Fakhrudin, N., Nurrochmad, A., & Wahyuono, S. (2024) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2024.101021 · Cited by 12
“Type 2 diabetes mellitus (T2DM) represents the most frequent type of DM, accounting for more than 90% of all DM cases globally [2].”
BackgroundMechanisms of Non-alcoholic Fatty Liver Disease and Beneficial Effects of Semaglutide: A Review
Alfawaz, S. A., Burzangi, A. S., & Esmat, A. (2024) · Cureus · doi:10.7759/cureus.67080 · Cited by 16
“The risk factors associated with T2DM and IR comprise obesity, higher calorie consumption, advancing age, lack of physical activity, and genetic susceptibility [24].”
BackgroundRecent advances in polymer-based nanoformulations for enhancing oral drug delivery in diabetes
Garg, S. S., Dey, R., Sharma, A., & Gupta, J. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106119 · Cited by 10
Gut Microbiota Disorders and Metabolic Syndrome: Tales of a Crosstalk Process
Nie, P., Hu, L., Feng, X., & Xu, H. (2024) · Nutrition Reviews · doi:10.1093/nutrit/nuae157 · Cited by 10
Rice Husk Silica Liquid Protects Pancreatic β Cells from Streptozotocin-Induced Oxidative Damage
Chen, H.-Y., Chiang, Y., Wang, K.-L., Huang, T., Ali, M. K., Shieh, T., Chang, H., Hong, Y.-H., & Hsia, S. (2021) · Antioxidants · doi:10.3390/antiox10071080 · Cited by 11
“The major pathogenesis involves the loss or destruction of pancreatic β cells, which in turn induces the state of imbalance between insulin secretion and blood sugar control in the body [2].”
BackgroundCurrent State and Principles of Basal Insulin Therapy in Type 2 Diabetes
Vargas‐Uricoechea, H. (2022) · Journal of Clinical Medicine Research · doi:10.14740/jocmr4660 · Cited by 13
Matowane, G. R., Ramorobi, L. M., Mashele, S. S., Bonnet, S. L., Noreljaleel, A. E. M., Swain, S. S., Makhafola, T. J., & Chukwuma, C. I. (2022) · Diabetic Medicine · doi:10.1111/dme.14905 · Cited by 8
Liu, Y., Chen, S., Ma, Y., Li, H., Lang, H., Li, Y., Wu, J., Zhou, M., He, Y., & Guo, E. (2022) · Nutrición Hospitalaria · doi:10.20960/nh.03838 · Cited by 9
Urbani, G., Distrutti, E., Biagioli, M., Marchianò, S., & Fiorucci, S. (2022) · Journal of Translational Science · doi:10.15761/jts.1000470 · Cited by 7
Martins, J. R. N., Lopes, S. C., Hurtado, H. N., da Silva, F. N., Villard, D. R., Taboga, S. R., Souza, K. L. A., Quesada, I., Soriano, S., & Rafacho, A. (2022) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2022.104046 · Cited by 10
Huo, Y., Grotle, A., McCuller, R. K., Samora, M., Stanhope, K. L., Havel, P. J., Harrison, M., & Stone, A. J. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2022.1063326 · Cited by 9
“Over time, however, the beta cells of the pancreas lose the ability to produce sufficient insulin, increasing the dependence on exogenous insulin and making this insulin resistant disease more similar to type 1 diabetes (Galicia-Garcia et al., 2020).”
BackgroundMartín‐Saladich, Q., Simó, R., Aguadé‐Bruix, S., Simó‐Servat, O., Aparicio, C., Hernández, C., Ramírez, C., Pizzi, M. N., Roque, A., Ballester, M. Á. G., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043250 · Cited by 9
“In parallel, IR has an effect on the liver as well, enhancing its gluconeogenesis and decreasing cellular glucose uptake in the liver, the muscle and the adipose tissue [5].”
Backgroundmir-98-5p regulates gluconeogenesis and lipogenesis by targeting PPP1R15B in hepatocytes
Khan, R., Verma, A. K., & Datta, M. (2023) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-023-00735-0 · Cited by 9
Zhang, J., Xi, Y., Fei, Q., Xu, J., & Hu, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1139157 · Cited by 11
“T2DM patients are primarily characterized by increased fat content around the abdomen, and this adipose tissue accelerates insulin resistance (IR) development through an inflammatory response (3).”
BackgroundAlshaikh, A. A., Alqarni, H. M., Assiri, H. A. H., Shlwan, M. A. M., AlJebreel, M. A. M., Almuaddi, A. S., Asiri, M. A., Almuidh, F. N. A., Qasim, N. Y. A., Alshahrani, O. A. S., et al. (2023) · Cureus · doi:10.7759/cureus.42807 · Cited by 8
Işıldar, B., Özkan, S., & Koyutürk, M. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300216 · Cited by 14
Singh, S., Kancharla, S., Kolli, P., Mandadapu, G., & Jena, M. K. (2023) · Biomedical and Biotechnology Research Journal (BBRJ) · doi:10.4103/bbrj.bbrj_205_23 · Cited by 10
Lee, K. A., Jin, H. Y., Kim, Y. J., Kim, S. S., Cho, E.-H., & Park, T. S. (2022) · Medicine · doi:10.1097/md.0000000000028823 · Cited by 9
Lim, Y. S., Ho, B., & Goh, Y. S. (2022) · Worldviews on Evidence-Based Nursing · doi:10.1111/wvn.12615 · Cited by 9
Research on Diabetes Prediction Method Based on Machine Learning
Paliwal, M., & Saraswat, P. (2022) · International Conference on Technological Advancements in Computational Sciences (ICTACS) · doi:10.1109/ictacs56270.2022.9988050 · Cited by 7
Initial study of the detection of ADAM 10 in the urine of type-2 diabetic patients
Gruba, N., Piwkowska, A., & Lesner, A. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106826 · Cited by 7
Croke, S., Volkmann, A.-M., Perry, C., Atkinson, R. A., Pruneddu, A., Morris, L., & Bower, P. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-068765 · Cited by 9
Antioxidant Activity of Natural Products from Medicinal Plants
Saavedra‐Molina, A., la Cruz, J. L., Landa‐Moreno, C. I., Murillo‐Villicaña, M., Garcia‐Berumen, C. I., Montoya-Pérez, R. D. C., Manzo‐Ávalos, S., Méndez, A. A., Salgado‐Garciglia, R., & Cortés‐Rojo, C. (2024) · Biochemistry · doi:10.5772/intechopen.1004272 · Cited by 8
Exosomes isolated from IMMUNEPOTENT CRP, a hemoderivative, to accelerate diabetic wound healing
Coronado, P. L. G., Molina, M. A. F., Triviño, D. G. Z., Hernández-Martínez, S. P., Castro-Valenzuela, B. E., Benavides, P. Z., & Padilla, C. R. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1356028 · Cited by 10
Rey, D. P., Echeverry, S. M., Valderrama, I. H., Rodríguez, I. A., Ospina, L. F., Silva, F. R. M. B., & Aragón, D. M. (2024) · Nutrients · doi:10.3390/nu16111669 · Cited by 12
“T2DM is characterized by defective insulin secretion by pancreatic β cells and tissue resistance to insulin responses, causing hyperglycemia, hyperinsulinemia, increased reactive oxygen species (ROS), oxidative stress, and adipose tissue hypertrophy, among other metabolic changes [3,4].”
BackgroundTey, S. L., Chee, W. S. S., Deerochanawong, C., Berde, Y., Lim, L., Boonyavarakul, A., Wakefield, B., Baggs, G. E., & Huynh, D. T. T. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1400580 · Cited by 8
Alsharairi, N. A. (2024) · Genes · doi:10.3390/genes15070942 · Cited by 7
Recent and Upcoming Therapies for Management of Type 2 Diabetes: A Review
Gokalani, R. A., Saiyed, M., Dey, A. K., & Sheikh, F. (2024) · Preventive Medicine Research & Reviews · doi:10.4103/pmrr.pmrr_12_24 · Cited by 8
Li, J., Li, M., Ke, H., Han, Y., Huang, Y., Zhou, Y., Luo, Z.-Q., Chen, C., & Feng, D. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003215 · Cited by 7
“[1] Although significant progresses have been made in understanding the pathology of T2D with abnormal insulin-secretion profiles, the molecular and cellular mechanisms of β cells remain largely uncertain.”
BackgroundRohold, C. K., Jørgensen, H. L., Vojdeman, F. J., Madsen, C. M., Olsen, A., Heegaard, A., Lind, B., Tjønneland, A. M., Schwarz, P., & Gæde, P. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02368-0 · Cited by 8
Li, J., Yin, M., Wang, Z., Xiong, Y., Fang, X., & Fang, H. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149241 · Cited by 7
Alshaikh, A. A., Alshehri, A., Alshehri, A. Z. A., Alobaid, A. S., Mohammed, A. A., Alshahrani, T. S. F., Albarqi, A. Z. M., Sultan, H. S. H., Alhussen, M., Shehri, A. D. A., et al. (2024) · Medicine · doi:10.1097/md.0000000000039895 · Cited by 8
“[5] .”
Background(Multi-) omics studies of ILC2s in inflammation and metabolic diseases
Kral, M., van der Vorst, E. P. C., Weber, C., & Döring, Y. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1473616 · Cited by 9
Prevalence and Determinants of Household Self-Reported Diabetes Mellitus in Gauteng, South Africa
Mokhele, S., & Mokhele, T. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21111537 · Cited by 7
Angiogenic effects of Type 2 diabetes on the dental pulp
Patel, S., Yang, E., Milne, T. J., Hussaini, H. M., Cooper, P. R., & Friedlander, L. T. (2024) · International Endodontic Journal · doi:10.1111/iej.14181 · Cited by 9
Feezan, A., Afzal, S., Shoaib, S. M., Rehman, K., Hussain, A., Akash, M. S. H., Shahid, M., & Sadaf, B. (2024) · Journal of Food Biochemistry · doi:10.1155/jfbc/8607956 · Cited by 7
Pathophysiological hallmarks in type 2 diabetes heterogeneity (review)
Datta, D., Kundu, R., Basu, R., & Chakrabarti, P. (2024) · Diabetology International · doi:10.1007/s13340-024-00783-w · Cited by 12
Scribante, A., Pellegrini, M., Ghizzoni, M., Pulicari, F., Giannì, A. B., & Spadari, F. (2024) · The Open Dentistry Journal · doi:10.2174/0118742106346940241212104004 · Cited by 10
Bhatia, Z., Kumar, S., & Seshadri, S. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01518-z · Cited by 7
Basith, S., Manavalan, B., & Lee, G. (2025) · Methods · doi:10.1016/j.ymeth.2025.01.003 · Cited by 9
Cisplatin Exposure Dysregulates Insulin Secretion in Male and Female Mice
Basu, L., Grieco-St-Pierre, L., Ching, M. E. A., Stead, J. D. H., Hanson, A. A., Palaniyandi, J., Vanzyl, E. J., Hoyeck, M. P., McKay, K. S., van Allen, K. A., et al. (2025) · Diabetes · doi:10.2337/db24-0419 · Cited by 10
Chen, F., Yang, Y., Yu, L., Song, L., Zhang, C., He, Y., Wu, L., Ma, W., & Zhang, B. (2025) · BMC Public Health · doi:10.1186/s12889-024-21266-2 · Cited by 9
Birhanu, A., Ambachew, S., Baye, N., Getnet, E., Admas, S., Gebrie, E., & Worede, A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0318775 · Cited by 7
Liu, X., Liu, X., Hu, Y., Wang, X., Yang, X., Bin, Y., Zhou, Y., Zhou, L., Fan, G., & Yang, J. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf022 · Cited by 5
Afshin, N., Mushtaq, N., Ahmed, M., Badshah, S., Wazir, S. M., Badshah, F., Sher, N., Alkahtani, J., Erċışlı, S., Elshikh, M. S., et al. (2025) · Biological Trace Element Research · doi:10.1007/s12011-025-04566-5 · Cited by 9
“The primary symptom of diabetes is abnormally high blood glucose levels [11].”
An update on current type 2 diabetes mellitus (T2DM) druggable targets and drugs targeting them
Uniyal, P., Panwar, S., Bhatt, A., Marianesan, A. B., Kumar, R., Singh, T. G., Tyagi, Y., Bushi, G., Gaidhane, A. M., & Kumar, B. (2025) · Molecular Diversity · doi:10.1007/s11030-025-11149-y · Cited by 11
“2) [24]. β-cell β-cell dysfunction has been conventionally connected with β-cell death.”
Exercise‐induced signalling in alleviating neuronal insulin resistance
Reddy, I., & Dey, C. S. (2025) · The Journal of Physiology · doi:10.1113/jp287750 · Cited by 8
Aguíñiga-Sánchez, I., Morales-Altamirano, A. M., Santiago-Osorio, E., Rosado-Pérez, J., Cadena-Íñiguez, J., Mendoza-Núñez, V. M., Weiss‐Steider, B., García-Gavia, G., Arista-Ugalde, T. L., Arreola-Gómez, N. A., et al. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.106499 · Cited by 7
Pawar, K., Kamble, R. N., & Patil, S. S. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106879 · Cited by 7
Plasma and urinary metabolomic signatures differentiate genetic and idiopathic Parkinson’s disease
Cotrin, J. C., dos Santos, G. C., Cadaxo, A. S., Pereira, J. S., Spitz, M., de Rosso, A. L. Z., Veras, R. P., Valente, A. P., Pimentel, M. M. G., & Santos-Rebouças, C. B. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149625 · Cited by 8
Karedath, J., Nall, S., Kaur, M., Lokhandwala, A., Aqel, Y., Abusal, A. M., Wei, C. R., & Allahwala, D. (2025) · Cureus · doi:10.7759/cureus.82497 · Cited by 16
“Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance and impaired insulin secretion, leading to hyperglycemia and an increased risk of microvascular and macrovascular complications [1].”
Jia, L., Liu, Y., Fu, B., Tian, Y., & Meng, X. (2025) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2025.2497486 · Cited by 7
Elbouzidi, A., Jeddi, M., Baraich, A., Taibi, M., Haddou, M., Hachlafi, N. E., Yahyaoui, M. I., Bellaouchi, R., Guerrouj, B. E., Chaabane, K., et al. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47070512 · Cited by 7
“Diabetes mellitus (DM) is a chronic metabolic disorder characterized by persistent hyperglycemia resulting from defects in insulin secretion, insulin action, or both [1].”
Targeting the molecular crosstalk between diabetes and lung cancer for therapeutic intervention
Azani, A., Avval, N. A., Meigoli, M. S. S., Imankhan, M., Asgari, P., Ebrahimisaraj, G., Morovatshoar, R., Hosseini, A. M., Mirzohreh, S.-T., Nouri, M., et al. (2025) · Discover Oncology · doi:10.1007/s12672-025-03264-x · Cited by 6
“[40– 45] Smoking and genetic factors Interaction between smoking, genetic predisposition, and immune response.”
Muguerza-Rodríguez, L., Mier, A., Ponce‐González, J. G., Casals, C., & Corral‐Pérez, J. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47070505 · Cited by 8
Guo, Y., Xue, T., Meng, X.-F., Yan, P., Zhang, M., Zhang, Q., Li, T., Shi, K., & Zhang, N. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157399 · Cited by 12
Emerging Roles of Post-Translational Modifications in Metabolic Homeostasis and Type 2 Diabetes
Kim, Y. K., & Kim, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311552 · Cited by 9
Zhuang, T., Pan, W., Zhang, Y., Wu, Y., Wang, X., & Li, P. (2025) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.70146 · Cited by 7
Fu, P., Huiyun, X., & Lijing, G. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1769497 · Cited by 7
Craciun, C. I., Măgureanu, D. C., Bocșan, I. C., Craciun, A. E., Buzoianu, A. D., & Maria Adriana, N. E. A. G. (2026) · Diabetology · doi:10.3390/diabetology7030059 · Cited by 10
Metadata
- Authors
- Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C.
- Affiliations
- Fundación Biofisika Bizkaia, Barrio Sarriena s/n., 48940 Leioa (Bizkaia), Spain
- Biofisika Institute (UPV/EHU, CSIC), Barrio Sarriena s/n., 48940 Leioa (Bizkaia), Spain
- Harvard University (US)
- CIC biomaGUNE (ES)
- Consejo Superior de Investigaciones Científicas (ES)
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-08-30
- Volume
- 21
- Issue
- 17
- Pages
- 6275
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7503727
- OpenAlex
- W3081655479
- Cited by
- 3,360
- References
- 297
- Citations by year
- 2026: 627 · 2025: 783 · 2024: 812 · 2023: 646 · 2022: 379 · 2021: 100 · 2020: 7
- FWCI
- 64.29
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Communities in ADDI (University of the Basque Country) (submittedVersion, other-oa)
- Communities in ADDI (Universidad del Pais Vasco) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Hispana (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- type 2 diabetes, insulin resistance, insulin secretion, pancreatic beta cells, insulin biosynthesis, insulin signaling, glucose homeostasis, gut dysbiosis, metabolic memory, nutrition, physical activity, atherosclerosis, cardiovascular risk
- MeSH terms
- Insulin Secretion, Animals, Blood Glucose, Diabetes Mellitus, Type 2, Homeostasis, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.